The company can even give data from a registry of sufferers addressed with Hemgenix to review its extensive-term security and performance.Based on the clinical industry experts consulted by CADTH, there are many unmet demands for hemophilia B. 1st, individuals with hemophilia B have a lifetime drawback and quality of life disadvantage in comparison